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ABSTRACT 
Purpose: This systematic literature review aimed to (1) summarize and explain the concept of Burden of 
Treatment (BoT) using the International Classification of Functioning, Disability and Health (ICF) termin- 
ology, and (2) inform the development of a future Comprehensive ICF Core Set for BoT. 
Method: Searches on EMbase, Medline, CINAHL and PsycINFO were conducted. Only qualitative studies 
were considered for inclusion. The screening and data extraction stages were followed by a ‘‘Best-fit’’ 
framework synthesis and content analysis, using the established ICF linking rules. Screening, data extrac- 
tion, quality appraisal and data analysis were performed by two independent researchers. 
Results: Seventeen studies were included in this review. The ‘‘Best–fit’’ framework synthesis generated 179 
subthemes which identified that BoT impacts negatively on body functions and structures, restricts valued 
activities and participation and influences contextual factors through life roles, self-identify and relation- 
ships. The identified subthemes were linked to 77 ICF categories. 
Conclusions: This study is part of the preparatory phase of a Comprehensive ICF Core Set for BoT and our 
findings will inform the further needed studies on this phase. The use of ICF terminology to describe BoT 
provides an accessible route for understanding this complex concept, which is pivotal for rethinking clinical 
practice. 
> IMPLICATIONS FOR REHABILITATION 
● Health professionals applying the ICF should consider the negative impact of interventions on patient’s 
life roles and self-identity, body functions and structures and on valued activities and participation. 
● Health professionals who may be concerned about the treatment burden being experienced by their 
patients can now use the ICF terminology to discuss this with the multidisciplinary team. 
● Poor adherence to rehabilitation programs may be explained by an increased BoT. This 
phenomenon can now be mapped to the ICF, and coded using a framework well known by multidis- 
ciplinary teams. 
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Introduction 
Patients’ decisions regarding treatment options, such as which treatment to receive and how much they adhere to 
treatment recommendations, are related to the anticipated and actual experience of undertaking the treatment,[1] 
particularly the perceived burden of treatment (BoT).[2] BoT has been described as the increased demand 
experienced from performing self-care activities, undertaking treatment regimens and monitoring health out- 
comes.[3] It also includes the impact of treatment on patient functioning and well-being.[4] Increased BoT is 
associated with non-adherence, wasted resources, poor health outcomes, reduced quality of life and, ultimately, with 
increased mortality.[3–7] Health professionals therefore need to be sensitive to recognizing, under- standing and 
reducing BoT, in order to balance the potential bene- fits and burdens of treatments and maximize adherence.[7,8] 
The International Classification of Functioning, Disability and Health (ICF), developed by the World Health 
Organization, provides 
a framework for the description of health and health-related states within a common terminology.[9,10] This 
classification, with its four components (body functions and structures, activities and participation, environmental 
factors and personal factors) reflects the biopsychosocial model in a unified and coherent view of various 
dimensions of health (biological, individual and social).[10] The ICF proposes that patients are not a ‘‘passive 
receiver of medical care’’.[11] Rather, their experiences of illness are more than just the direct impact of disease 
on body functions and structures (i.e., physiological systems or anatomical structures): they are influenced by the 
effect of health conditions on their ability to undertake valued activities (such as walking and dressing) and to 
participate in life situations (such as work, leisure and family). Each patient’s ill- ness experience is also influenced 
by both environmental factors (i.e., physical, social and attitudinal environment in which the patient lives, such as 
family support or wheelchair provision) and personal factors (i.e., attributes of the patient with an internal influence 
on functioning and disability, such as resilience or skills). The 
ICF captures these various perspectives of functioning, disability and health, and has been increasingly applied by 
healthcare professionals worldwide, as the reference framework for describing health according to the 
biopsychosocial model.[11] 
The concept of BoT has not been previously aligned with the ICF framework; however, the conceptual connections 
are apparent. Patients’ experiences and perceptions of BoT have been shown to relate to various factors such as fatigue 
or pain (body functions),[6,12] family circumstances, treatment design, health care systems (environ- mental factors) [4–
8,12–16] and personal factors.[4–8,12–16] Many health professionals are familiar with and applying the ICF in research 
and clinical practice.[11] The ICF framework can therefore act as a useful tool for elucidating the complex concept of 
BoT. As a novel concept, BoT is receiving increasing attention in the literature [17,18] however, robust outcome 
measures, to cover the complexity of this concept across conditions are still being developed and fundamental 
understanding of this concept, based on the perspectives of patients and researchers, has been generated by qualitative 
studies.[4,18] Linking the findings from these studies with the ICF will inform future developments of an ICF Core Set for 
BoT. 
The development of ICF Core Sets is recommended by the 
World Health Organization as they represent a list of categories specifically relevant for a health condition or 
context, promoting the applicability of the ICF in clinical practice.[19,20] ICF Core Sets are designed in 
comprehensive and/or short versions. The former are exhaustive lists of categories used to describe a health condi- 
tion or context; the latter represent only the most essential of these categories.[20] Recent guidance on the 
development of ICF Core Sets has been published and recommends a three stage pro- cess: a preparatory phase, 
followed by an international ICF consensus conference and a last phase, which consists of the implementation of the 
first version of the ICF Core Set.[20] The preparatory phase includes a systematic literature review which aims to 
gather the perspectives of researchers and identify aspects of functioning that can then be linked to the ICF through 
the established linking rules.[9,20] The type and characteristics of the systematic review may vary in this 
preparatory phase.[20] In this particular case, it is important to consider that the concept of BoT is complex and 
recent in the literature,[3,18,21] and has not yet been widely linked to measurement tools.[22] 
This systematic qualitative literature review aimed to (i) sum- 
marize and explain the concept of BoT using the ICF terminology, and (ii) inform the development of a future 
Comprehensive ICF Core Set for BoT. The results of this study will facilitate communication within multidisciplinary 
teams regarding BoT; allow the concept of BoT to be mapped to the ICF and therefore under- stood and 
recognized among more health professionals; and ultimately, inform the development of instruments/assessment 
tools of BoT. 
 
Methods 
This qualitative literature review was guided by the Preferred Reporting Items for Systematic Reviews and Meta-
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Analyses (PRISMA) statement, developed to promote optimal clarity, transparency and reliability of systematic 
literature reviews.[23] The fol- lowing sections adopted the PRISMA terminology, with the necessary adaptations for 
a qualitative literature. 
 
Eligibility criteria 
Qualitative studies that focused on patients’ experiences of BoT in any health condition were sought. The decision to 
only include qualitative studies was based on the need to gain a rich and deep understanding of ‘‘what’’ BoT is, from 
the perspective of both patients and researchers, and to then link this to ‘‘how’’ it is represented in the ICF. 
Therefore, studies met the inclusion criteria if they: (1) used both qualitative data collection and analysis methods; 
(2) contained the expressions ‘‘treatment burden’’ or ‘‘burden of treatment’’ in the title or abstract and (3) considered 
BoT as the main focus or included BoT in the research questions. Studies that may have contained the expressions 
‘‘treatment burden’’ or ‘‘bur- den of treatment’’ only in the body of the paper, but not in the title or abstract, were 
excluded. This was used as an indicator of studies that have BoT as their main focus, and would therefore explore 
this topic in greater depth. Studies describing ‘‘burden of disease’’, ‘‘caregiver burden’’, ‘‘financial burdens to 
society or health services’’; not written in English or Portuguese; and, those not including qualitative data were also 
excluded. 
 
Search and information sources 
The search was undertaken electronically in four different data- bases – EMbase, Medline, CINAHL and 
PsycINFO – aiming to achieve an extensive search strategy that would cover the avail- able studies focusing on 
BoT. The key words ‘‘treatment burden’’ OR ‘‘burden of treatment’’ were used in all the listed databases. No 
restrictions were established regarding treatment intervention, health condition, participant demographics, year of 
publication or study settings. No filters were used in any of the databases. The search was initially conducted in 
June 2012 and updated in December 2014. 
 
Screening and study selection 
Two blinded researchers screened the titles, abstracts and, when necessary, full texts of all studies to determine 
inclusion and exclu- sion and remove duplicates. In order to avoid early incorrect filter- ing of qualitative studies, no 
restrictions regarding paradigm were set on the data bases and the identification of qualitative studies was 
undertaken manually, during the screening of titles and abstracts.[24] 
 
Quality appraisal 
The Critical Appraisal Skills Program Checklist for qualitative studies 
[25] was used to assess the quality of the included studies. Quality appraisal was initially performed independently, 
and then dis- cussed and agreed, by two researchers [SH and KH]. An increasing body of evidence proposes that 
neither study design nor quality assessment scores should be used to exclude qualitative studies.[26,27] All 
studies were therefore included and analysed regard- less of their design or quality score. Quality scores are provided 
to enrich the description of the included studies. 
 
Synthesis of results 
The extracted data were analysed using two methods: firstly a qualitative ‘‘Best-fit’’ framework synthesis; secondly 
a content analysis applying the ICF linking rules.[9] Both methods are described below. ‘‘Data’’ were defined as both 
direct primary quotations presented in the included studies and authors’ analytical interpretations presented in 
either the results/findings or discussion sections. The use of both ‘‘quotations’’ and ‘‘analytical interpretations’’ as 
data for this literature review aimed to allow the gathering of a richer set of data to better illustrate the concept of 
BoT. This approach has been used in previous reviews of qualitative studies.[28] 
‘‘Best-fit’’ framework synthesis 
‘‘Best-fit’’ framework synthesis uses the conceptual categories of an existing model or theory to facilitate thematic data 
extraction and analysis. This synthesis method offers the means to test, reinforce and build on an existing published 
model, conceived for a potentially different but relevant population or context.[26,27,29] The ICF was selected as the 
model of ‘‘Best-fit’’ to explore how BoT may be conceptualized within a biopsychosocial perspective of health.[10] 
An a priori framework using the ICF components (body functions and structures, activities and participation, 
environmental factors and personal factors) was used to extract data from the included studies. NVivo software 
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(v(0).10 QSR International Pty Ltd., Melbourne, AU) was used to aid data management. 
Framework analysis allows a description of both a priori and newly emerged themes. Following extraction, data 
attributed to the a priori framework were further thematically analysed, grouping similar issues to generate a list of 
emergent themes and subthemes. For instance, the quotes ‘‘One individual adopted a more generally sedentary lifestyle to 
prevent symptoms rather than undertake physical activity alongside their peers’’ [16] and ‘‘Fatigue alongside breathlessness 
and cough, was reported as a factor limiting ability to keep up with peers, and also as a cause of low motivation’’ [16] were 
both coded under the theme ‘‘Participation linked to body functions and structures’’ and the sub- theme ‘‘Symptoms 
limiting participation with peers’’. 
The themes and subthemes and the links and conflicts between them were thereafter used to explain the concept 
of BoT from the perspective of the ICF. 
 
Content analysis following the ICF linking rules 
Content analysis, applying the ICF linking rules,[9] was undertaken to classify the subthemes generated as 
previously described, against the most appropriate ICF category. According to these rules, meaningful concepts 
should be extracted from a text prior to assigning the ICF categories.[30] The example below, extracted from the 
analysis, illustrates this process: 
The subtheme (generated by ‘‘Best-fit’’ synthesis) ‘‘Having a rou- tine as a strategy to reduce treatment workload and 
promote adherence’’ was analysed and the following meaningful concepts were identified: (i) ‘‘having a routine as a 
strategy to reduce treatment workload’’; (ii) ‘‘having a routine as a strategy to promote adherence’’ and (iii) ‘‘reduced 
workload promotes adherence’’. 
 
 
 
 
 
Two researchers experienced in using the ICF and with a deep understanding of the concept of BoT [ACG and 
CJ] independently linked the meaningful concepts to the appropriate ICF categories. The example above was 
coded as d230 (carrying out a daily rou- tine); the concepts ‘‘treatment workload’’ and ‘‘adherence’’ were coded as 
not covered by the ICF and the concept ‘‘having coping strategies’’ was coded as personal factors. The agreement 
between the codifications of both researchers was calculated with Cohen’s Kappa statistics,[31] using IBM SPSS 
statistics (Version 21, IBM Corp. Released 2012, Armonk, NY). The strength of agreement associated to the 
Cohen’s Kappa statistics can be classified as poor (<0), slight (0.00–0.20), fair (0.21–0.40), moderate (0.41–0.60), sub- 
stantial (0.61–0.80) or almost perfect (0.81–1.00).[32] Any disparities were discussed by the same researchers, a third 
party [SHD] resolved disagreements and a final list was generated. 
 
Results 
Study selection 
The search generated 1736 studies. Once duplicates (n 590) were removed, 1146 abstracts and titles were 
screened; 378 full texts were considered for eligibility. Studies not using qualitative meth- ods (n  167),  or  not  
exploring  patients’  perspective  of  BoT  (n 194) were excluded. Seventeen studies met the inclusion crite- ria and 
were included in this review. A PRISMA flow chart illustrating the study selection process is presented in Figure 1. 
 
Study characteristics 
The samples of the included studies show a wide range of ages (from 7 to 96 years old), health conditions and 
countries. Further details about the included studies can be found in Table 1. 
The quality scores regarding aspects such as recruitment, data collection, validity, methodology, relationship 
between researchers and participants, ethical issues, data analysis and relevance of the findings were considered 
high in all included studies. However, the ‘‘relationship between researchers and participants’’ and a detailed 
discussion of ‘‘ethical issues’’ were often less clear. 
 
ICF components applied to the concept of burden of treatment: best-fit framework synthesis 
Burden of treatment and body functions and structures 
All studies reported BoT experienced as either physical and/or emotional side effects. Applying the ICF, these side-
effects can be considered as treatment induced impairments to body functions and structures additional to those 
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generated by the disease itself. These included pain, fatigue and nausea and altered emotional functions, such as 
feeling anxious or depressed. For instance, patients using Percutaneous Endoscopic Gastrostomies described a large 
range of treatment generated physical impairments: 
Blockage, leakage, site infection, tube falling out, emesis caused by excessively rapid infusion of feed, sleep difficulties due to 
noise from machines, bleeding from PEG [Percutaneous Endoscopic Gastrostomies] sites when coughing, and malodorous leakage 
from the stoma. Feeling seek and terrible coughing that leads to vomiting, nausea, regurgitation or heartburn (.. .) [and] abdominal 
pain.[8] 
The included studies also described the increased treatment workload (BoT), which was frequently required in 
order to manage the side-effects (impairments in body functions and structures) generated by the treatments. 
The primary issue during the first injections was adjusting to the cycle of symptoms and ‘side effects’.[12] 
Finally, impairments in body functions and structures often reduced patients’ physical capacity to engage with the 
recommended treatment requirements. For instance a patient with diabetes, stated: 
I was supposed to look at my feet once a week but I can’t see my feet because of my poor vision.[4] 
Treatment induced impairments were also frequently reported as contributing to restrictions in patients’ 
activities and their ability to participate in life roles, and it was the impact of treatments on participation restriction 
that appeared to be most burdensome for patients. 
People wanted me to come and play bridge and to do other things, [but] I think, on the higher dose of the prednisone I feel tremulous 
and it is more difficult to concentrate.[4] 
How BoT relates to activities and participation is described under the following section. 
 
Burden of treatment and activities and participations 
The studies also identified that treatment regimens often required patients to engage in a complex set of new and 
additional
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treatment activities; for instance, exercising, learning about treatment options and modifying diets. These activities 
took time and impacted on patients’ ability to engage in their valued activities. According to the included studies, 
participation in valued occupational, social and leisure activities, sports or other hobbies contributed to patients’ 
identity and sense of self. Maintaining these activities was therefore seen as a priority and a way of keeping a 
‘‘normal life’’. For instance, one woman worried about the impact of injections for spasmodic dysphonia on her valued 
activity of hiking: 
I’m more concerned that [if I have the treatment] I’m not going to be able to go hiking with my friends.[12] 
    Many patients therefore engaged in complex decision making and prioritization, adapting 
their life to enable both their treatment and meaningful activities to occur. 
A friend called me ‘Hey, I have tickets to a baseball game. Do you want to go?’ I am like, ‘Well, can I plan my treatment around 
it?’.[13] 
 
However, the ability to maintain a stable self-identity by participation in valued activities and roles was often 
seen as a greater priority than engaging in treatment. Participants of the included studies described the process of 
making rational decisions to mod- ify or even cease their adherence to treatments, in order to preserve aspects of 
participation, such as career or social/leisure activities: 
When I am out with friends, I don’t carry them (enzymes) like my parents tell me to.[13] 
Conversely, when treatment activities were meaningful, compatible with patients’ valued activities or caused less 
disruption to participation were seen as less burdensome: 
I used to not be able to do anything when I went to parties and now [thanks to oral immunotherapy] I can sit with other kids and 
actually enjoy ice cream instead of watching ..  . I was sort of glad I could be more like normal kids.[36] 
A further link was identified between the concept of BoT, activities and participation and environmental factors. 
For instance, the financial costs of treatment (which would be classified as environ- mental factors) were described 
as a factor contributing to a restriction in family leisure activities (activities and participation). 
Money spent on obtaining treatment had a negative impact on family leisure and social/sporting activities.[7] 
In other cases, where treatment-induced activity restrictions might otherwise have led to non-adherence, 
involvement and sup- port of relatives (also considered environmental factors) increased patients’ capacity to engage 
in treatment and promoted adherence. 
I’m getting a repeat [prescription], my daughter (takes) it up to the chemist and X in the chemist (takes) it to the doctor, (gets) everything 
signed and it will be ready today, so my daughter will bring it down.. .. I can’t get up there.. ..[5] 
Further information as to how BoT relates to the environmental factors is described in the following section. 
 
Burden of treatment and environmental factors 
Environmental factors were reported as sources of BoT by all studies in this review. Aspects such as health policies 
and health professionals’ attitudes were described as causes of BoT through their disruption to patients’ self-identity, 
as demonstrated by this quote, about a patient with tuberculosis: 
[She] Felt she had no say over her treatment and could not approach healthcare staff with her concerns, for fear of 
recrimination.[15] 
Family support, attitudes of health professionals, architectural barriers or treatment related stigma clearly 
worked as either barriers to or facilitators of treatment which may influence the perception of BoT. Others were 
considered responsible for triggering a more complex cycle of burden. 
Treatment burden encompassed a cyclical aspect. For example, contradictory advice on treatment by health care professionals (health 
care access burden) could lead to polypharmacy (medication burden), which could then result in both a requirement for extra time to 
organise medications (time burden) and extra strain on financial resources (financial burden).[7] 
However, it is important to highlight that environmental  factors were not just acting as triggers, barriers or 
facilitators, but were also negatively affected  by  the  treatment.  An example commonly found in the included 
studies was the negative impact of treatment regimens on patients’ relation- ships and support received from  
family  and  friends,  which  can both be linked to environmental factors (support and relationships) and activities 
and participation (particular inter- personal relationships). 
It was down to the point where it was nothing but, you know, ‘‘the rules’’.. .It is hard for a parent to be a nurse at the same time. It 
just changes the whole dynamics of the relationship.. ..[38] 
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Burden of treatment and personal factors 
Personal characteristics influenced each patient’s psychological and emotional capacity to deal with a treatment 
and their perception of the burden generated: 
The ability to overcome fear and manage symptoms varies between individuals, with less distress expressed in situations of self-
confidence.[16] 
The BoT literature also identified age as an important factor in patients’ ability and willingness to tolerate 
treatment burdens: 
I’m too old now, that dialysis thing is more for younger people.. . Not for me.[14] 
Finally, treatment regimens can also be seen to negatively influence personal factors. Adhering to complex and 
potentially stigmatizing treatment regimes, as well as the tendency for people to be viewed as ‘‘patients’’ rather 
than ‘‘individuals’’ may directly influence patients’ self-identity: 
The parameters of normality in patients with PCD (Primary Ciliary Dyskinesia) are developed through experiences, achievements, 
expectations and comparison with healthy peers.[16] 
The impact of treatment on personal factors, such as individual priorities, preferences or sense of normality, was 
described by patients as reasons not to adhere: 
My time is more valuable to me than that. It’s not worth it for me.. ..I just don’t [do the treatment] because it is more fun not to.[5] 
Although, non-adherence can result in deterioration of patients’ health status (thus having direct consequences 
on body functions and structures), patients in the included studies were often aware of these potential negative 
consequences but still decided to prioritize their personal life. 
Patients’ treatment adherence behaviour is to some extent a product of rational decisions by the patient after contemplating perceived 
benefits and weighing them against perceived risks.’’(.. .) ‘‘Instances of non-adherence take place even when patients are aware of 
direct immediate negative consequences.[6] 
The concept of burden of treatment and the ICF categories: con- tent analysis following the ICF linking rules 
   There was substantial inter-rater agreement for the initial coding (ICF component: k=0.748, 95% CI=0.71–
0.792; 1st t level:   k=0.811, 95% CI=0.768–0.854; 2nd level: k=0.744, 95%  CI 0.697–0.791; 3rd level: k 0.715, 
95% CI=0.620–0.805). 
The thematic analysis of the studies included in this review (described above) generated 179 subthemes. Using 
the ICF linking rules,[9] these subthemes were coded to 77 ICF categories: 36 of which refer to the body functions 
and structures, 19 to the activities and participation, and 22 to the environmental factors (Table 2). Only the 1st and 
2nd level categories are presented in Table 2, when a 3rd level category was agreed, the equivalent 2nd level was 
selected. 
Additionally, 44 meaningful concepts emerged from the second stage of the analysis and were not possible to link 
to a specific ICF category. These included 33 personal factors (which have not yet been classified by the ICF) and 
11 ‘not-covered’ concepts by the ICF, identified as ‘‘nc’’. Tables 3 and 4 list all personal factors and concepts 
identified as ‘‘nc’’, respectively. A table with a list of sub- themes, its meaningful concepts and the corresponding ICF 
codes is available as Supplementary material. 
 
Discussion 
The present systematic review and best–fit analysis is, to our knowledge, the first to explain the concept of BoT 
using the standardized ICF terminology. The content analysis generated lists of ICF 
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categories (Tables 2–4) that form the first list of candidate categories of a future ICF Core Set for BoT. These 
findings represent a robust base of knowledge that can now inform and be complemented with further studies of 
the preliminary phase of the development of a Comprehensive ICF Core Set,[20] namely qualitative studies and 
expert surveys using our findings as a framework. 
BoT has been shown to impact negatively on body functions and structures and restrict valued activities and 
participation, life roles and self-identity. Environmental and personal factors were shown to shape the experience of 
BoT. For instance, strong family support can reduce the perception of burden; similarly lack of appropriate 
equipment can increase the perceived BoT. Conversely, BoT can also impact on personal and environmental 
factors such as when treatment obligations have a negative impact on family relationships and family support. This 
description of BoT using the ICF terminology can be linked to previous studies exploring the concept of BoT, where it 
has been described as a bio- graphical (self-identity; personal factors), relational (environmental factors and activities 
1
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and participation) and biological (body functions and structures) disruption.[18]The findings of this literature review 
also represent an import- ant contribution for future developments of the ICF itself. Our ana- lysis found the current 
list of ICF categories insufficient to fully describe BoT. Many fundamental BoT concepts such as ‘‘adher- ence’’, 
‘‘capacity’’ and ‘‘workload’’ [3–5,18] are ‘‘not covered’’ by the ICF (Table 4). This is, nevertheless, an understandable 
finding, given that the concept of BoT post-dates the development of the ICF framework. Other concepts such as 
‘‘treatment goals’’ or ‘‘treatment outcomes’’ were too general to be linked to the ICF and were coded as ‘‘not 
defined’’. Additionally, many concepts where linked to Personal Factors which have not yet been specified by the 
ICF, although BoT theory places a significant emphasis on how treatments affect and are affected by people’s 
personal identi- ties.[3] This study has begun to delineate and specify some of the important concepts under the 
component personal factors and highlighted the importance of contextual factors in general. These have relevance 
beyond a future ICF Core Set for BoT and can inform future developments of the ICF document itself.[9] 
 
Strengths and limitations and future directions 
BoT is a new concept which, authors have argued, has the potential to radically change the way that interventions 
are prescribed and managed in the patient/professional relationship.[3,18,21] However, BoT may be unfamiliar to 
many health professionals. By using the uniform terminology of the ICF, this study enables health professionals to 
more readily access a potentially complex,[21] but highly relevant theory. 
This study has its limitations. Including only qualitative studies, which expressly used the terms ‘‘Burden of 
Treatment’’ or ‘‘Treatment Burden’’ may have resulted in the exclusion of studies which explore the concept but 
without using the same termin- ology. A further limitation, common to all qualitative literature reviews, is that some 
of the information and context provided by the original participants may have been excluded from the original papers 
and therefore, lost to the secondary analysis. Lastly, the inclusion of all relevant qualitative studies regardless of 
their quality may have influenced our findings. 
This study sought to explore the links between BoT and the ICF across a range of conditions and treatments. This 
was an appropriate approach for demonstrating the conceptual similarities between the two models. However, this 
approach of combining conditions could potentially lead to an infinite number of categories, especially in the 
component body functions and structures. As BoT research progresses into more conditions, it may become more 
appropriate to incorporate the important BoT factors into the condition specific Core Sets. 
Future studies to complete the preparatory phase of a future ICF Comprehensive Core Set for BoT are 
necessary. Qualitative research involving a range of stakeholders (patients, healthcare professionals, policy-
makers and caregivers) is needed. Furthermore, the need of developing outcome measures of BoT has also been 
suggested in previous literature;[4,5] the ICF could provide a useful framework for this. 
 
Conclusion 
BoT impacts negatively on body functions and structures and restricts valued activities and participation, life roles 
and self-identity. Contextual factors have a dual role both influencing and being influenced by treatment burden. The 
use of ICF terminology to describe BoT provides an accessible route for understanding this concept which although 
complex is pivotal for rethinking clinical practice. This may lead to recognition that BoT is an important 
1
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consideration for treatment plans and patient adherence. Additional studies are also necessary complete the 
preparatory phase of development of a future Comprehensive ICF Core Set for BoT. 
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